Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR3663 host gene (MIR3663HG) is a human gene located on chromosome 10 encoding a long non-coding RNA (lncRNA)[2][3]. It serves as the host for the microRNA miR-3663. MIR3663HG itself is not known to be a therapeutic target or associated with direct disease roles. Its most studied relevance is as a host for miR-3663, which acts as a tumor suppressor in gastric cancer through modulation of cell cycle regulators such as Cyclin D1 and retinoblastoma protein, with low miR-3663-3p expression linked to recurrence risk in patients[1]. No drugs, safety concerns, or biomarker status are directly attributed to MIR3663HG.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR3663 host gene (non-protein coding) (MIR3663HG).